Abstract
Although it has been known for many years that certain viruses have something to do with tumor induction, in most instances there has been no specific evidence that the individual tumor cell had been directly transformed by a given virus. This sort of evidence was available only in the case of those RNA viruses, such as the avian leukoses, where the infected transformed cell continues to produce infectious virus. In the DNA virus-induced tumors, which are frequently free of infectious virus, there was no easy, direct way of establishing the etiological relationship. However, with the discovery in recent years that virus-induced tumors contain specific new antigens, a ready means of identification became available. There is good reason to believe that these antigens will be present in all virus-induced tumors, since one type or another has been found in all classes of tumors thus far adequately examined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Axelrad, A. A.: Changes in resistance to the proliferation of isotransplanted Gross virus-induced lymphoma cells, as measured with a spleen colony assay. Nature 199, 80 (1963).
Basses, R.: Antigenic differences between normal and polyoma virus-transformed cells. II. In vitro evidence for a virus-induced antigen. Cancer Res. 24, 1216 (1964).
Berman, L. D., and Rowe, W. P.: A study of the antigens involved in adenovirus 12 tumorigenesis by immunodiffusion techniques. J. Exptl. Med. 121, 955 (1965).
Bianco, A. R., Glynn, J. P., and Goldin, A.: Immunity against isotransplants of Rauscher virus-induced leukemia. Proc. Am. Assoc. Cancer Res. 5, 5 (1965).
Black, P. H., Rowe, W. P., Turner, H. C., and Huebner, R. J.: A specific complement-fixing antigen present in SV40 tumor and transformed cells. Proc. Natl. Acad. Sci. 50, 1148 (1963).
Defendi, V.: Effect of SV40 virus immunization of growth of transplantable SV40 and polyoma virus tumors in hamsters. Proc. Soc. Exptl. Biol. Med. 113, 12 (1963).
Dulbecco, R., Hartwell, L. H., and Vogt, M.: Induction of cellular DNA synthesis by polyoma virus. Proc. Natl. Acad. Sci. 53, 403 (1965).
Evans, C. A., Weiser, R. S., and Ito, Y.: Antiviral and antitumor immunologic mechanisms operative in the Shope papilloma-carcinoma system. Cold Spring Harbor Symposium on Quant. Biol. 27, 453 (1962).
Fink, M. A., and Malmgren, R. A.: Fluorescent antibody studies of the viral antigen in a murine leukemia (Rauscher). J. Natl. Cancer Inst. 31, 1111 (1963).
Fink, M. A., Malmgren, R. A., Rauscher, F. J., Orr, H. C., and Karon, M.: Application of immunofluorescence to the study of human leukemia. J. Natl. Cancer Inst. 33, 581 (1964).
Gerber, P.: Virogenic hamster tumor cells: Induction of virus synthesis. Science 145, 833 (1964).
Gilden, R. V., Carp, R. I., Taguchi, F., and Defendi, V.: The nature and localization of the SV40-induced complement-fixing antigen. Proc. Natl. Acad. Sci. 53, 684 (1965).
Gilead, Z., and Ginsberg, H. S.: Characterization of a tumorlike antigen in type 12 and type 18 adenovirus-infected cells. J. Bacteriol. 90, 120 (1965).
Girardi, A. J.: Prevention of SV40 virus oncogenesis in hamsters. I. Tumor resistance induced by human cells transformed by SV40. Proc. Natl. Acad. Sci. 54, 445 (1965).
Glynn, J. P., Bianco, A. R., and Goldin, A.: Studies on induced resistance against isotransplants of virus-induced leukemia. Cancer Research 24, 502 (1964).
Goldner, H., Girardi, A. J., Larson, V. M., and Hilleman, M. R.: Interruption of SV40 virus tumorgenesis using irradiated homologous tumor antigen. Proc. Soc. Exptl. Biol. Med. 117, 851 (1964).
Habel, K., and Silverberg, R. J.: Relationship of polyoma virus and tumor in vivo. Virology 12, 463 (1960).
Habel, K.: Resistance of polyoma virus immune animals to transplanted polyoma tumors. Proc. Soc. Exptl. Biol. Med. 106, 722 (1961).
Habel, K.: Immunological determinants of polyoma virus oncogenesis. J. Exptl. Med. 115, 181 (1962).
Habel, K.: Polyoma tumor antigen in cells transformed in vitro by polyoma virus. Virology 18, 553 (1962).
Habel, K.: Antigenic properties of cells transformed by polyoma virus. Cold Spring Harbor Symposia on Quant. Biol. 27, 433 (1962).
Habel, K.: The relationship between polyoma virus multiplication immunological competence, and resistance to tumor challenge in the mouse. Ann. N. Y. Acad. Sci. 101, 173 (1962).
Habel, K., and Eddy, B. E.: Specificity of resistance to tumor challenge of polyoma and SV40 virus-immune hamsters. Proc. Exptl. Biol. Med. 113, 1 (1963).
Habel, K.: Specific complement-fixing antigens in polyoma tumors and transformed cells. Virology 25, 55 (1965).
Habel, K., Jensen, F., Pagano, J. S., and Koprowski, H.: Specific complement-fixing tumor antigen in SV40-transformed human cells. Proc. Soc. Exp. Biol. Med. 118, 4 (1965).
Habel, K.: Cancer Research, to be published.
Habel, K.: Intern. Symposia Immunopathol., Monaco, in press (1965).
Hamburg, V. P., and Svet-Moldavsky, G. J.: Artificial heterogenization and tumours by means of Herpes Simplex and polyoma viruses. Nature (London) 203, 772 (1964).
Hanafusa, H., Hanafusa, T., and Rubin, H.: The defectiveness of Rous sarcoma virus. Proc. Natl. Acad. Sci. 49, 572 (1963).
Hare, J. D.: Transplant immunity to polyoma virus induced tumors. I. Correlations with biological properties of virus strains. Proc. Soc. Exptl. Biol. Med. 115, 805 (1964).
Hartley, J. W., Rowe, W. P., Capps, W. I., and Huebner, R. J.: Complement fixation and tissue culture assays for mouse leukemia viruses. Proc. Natl. Acad. Sci. 53, 931 (1965).
Hellström, L.: Distinction between the effects of antiviral and anticellular polyoma antibodies on polyoma tumor cells. Nature 208, 652 (1965).
Huebner, R. J., Rowe, W. P., Turner, H. C., and Lane, W. T.: Specific adenovirus complement-fixing antigens in virus-free hamster and rat tumors. Proc. Natl. Acad. Sci. 50, 379 (1963).
Huebner, R. J., Armstrong, D., Okuyan, M., Sarma, P. S., and Turner, H. C.: Specific complement-fixing viral antigens in hamster and guinea pig tumors induced by the Schmidt-Ruppin strain of avian sarcoma. Proc. Natl. Acad. Sci. 51, 742 (1964).
Huebner, R. J., Pereira, H. G., Allison, A. C., Hollinshead, A. C., and Turner, H. C.: Production of type-specific C antigen in virus-free hamster tumor cells induced by adenovirus type 12. Proc. Natl. Acad. Sci. 51, 432 (1964).
Huebner, R. J., Casey, M. J., Chanock, R. M., and Schell, K.: Tumors induced in hamsters by a strain of adenovirus type 3: sharing of tumor antigens and “neoantigens” with those produced by adenovirus type 7 tumors. Proc. Natl. Acad. Sci. 54, 381 (1965).
Jonsson, N., and Sjögren, H. O.: Further studies on specific transplantation antigens in Rous sarcoma of mice. J. Exptl. Med. 122, 403 (1965).
Khera, K. S., Ashkenazi, A., Rapp, F., and Melnick, J. L.: Immunity in hamsters to cells transformed in vitro and in vivo by SV40. J. Immunol. 91, 604 (1963).
Kit, S., Frearson, P. M., and Dubbs, D. R.: Enzyme induction in polyoma-infected mouse embryo cells. Fed. Proc. 24, 596 (1965).
Klein, G., Sjögren, H. O., Klein, E., and Hellström, K. E.: Demonstration of resistance against methyl icholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res. 20, 1561 (1960).
Klein, E., and Klein, G. L.: Antigenic properties of lymphomas induced by the Moloney agent. J. Natl. Cancer Inst. 32, 547 (1964).
Klein, G., Sjögren, H. O., and Klein, E.: Demonstration of host resistance against isotransplantation of lymphomas induced by the gross agent. Cancer Res. 22, 955 (1962).
Koch, M. A., and Sabin, A. B.: Specificity of virus-induced resistance to transplantation of polyoma and SV40 tumors in adult hamsters. Proc. Soc. Exptl. Biol. Med. 113, 4 (1963).
Law, L. W.: Neoplasms in thymectomized mice following room infection with polyoma virus. Nature 205, 672 (1965).
Law, L. W., and Dawe, C. J.: Influence of total body X-irradiation on tumor induction by parotid tumor agent in adult mice. Proc. Soc. Exptl. Biol. Med. 105, 414 (1960).
Leventhal, J. D., Jakobovits, M., and Eaton, M. D.: Polyoma disease and tumors in mice: the distribution of viral antigen detected by immunofluorescence. Virology 16, 314 (1962).
Noyes, W. F., and Mellors, R. C.: Fluorescent antibody detection of the antigens of the Shope papilloma virus in papillomas of the wild and domestic rabbit. J. Exp. Med. 106, 555 (1957).
Old, L. J., Boyse, E. A., and Stockert, E.: Typing of mouse leukemias by serological methods. Nature 201, 777 (1964).
Old, L. J., and Boyse, E. A.: Antigens of tumors and leukemias induced by viruses. Fed. Proc. 24, 1009 (1965).
Pasternak, G., and Graffi, A.: Induction of resistance against isotransplantation of virus-induced myeloid leukemias. Brit. J. Cancer 17, 532 (1963).
Pope, J. H., and Rowe, W. P.: Detection of specific antigen in SV40-transformed cells by immunofluorescence. J. Exptl. Med. 120, 121 (1964).
Rapp, F., Kitahara, T., Butel, J. S., and Melnick, J. L.: Synthesis of SV40 tumor antigen during replication of simian papovavirus (SV40). Proc. Natl. Acad. Sci. 52, 1138 (1964).
Rogers, S.: Induction of arginase in rabbit epithelium by the Shope rabbit papilloma virus. Nature 183, 1815 (1959).
Rowe, W. P., Hartley, J. W., Law, L. W., and Huebner, R. J.: Studies of mouse polyoma virus infection. III. Distribution of antibodies in laboratory mouse colonies. J. Exptl. Med. 109, 449 (1959).
Rowe, W. P.: The epidemiology of mouse polyoma virus infection. Bact. Rev. 25, 18 (1961).
Sabin, A. B., Shein, H. M., Koch, M. A., and Enders, J. F.: Specific complement-fixing tumor antigens in human cells morphologically transformed by SV40. Proc. Natl. Acad. Sci. 52, 1316 (1964).
Sabin, A. B., and Koch, M. A.: Source of genetic information for specific complement-fixing antigens in SV40 virus-induced tumors. Proc. Natl. Acad. Sci. 52, 1131 (1964).
Sachs, L.: Transplantability of an x-ray-induced and a virus-induced leukemia in isologous mice inoculated with a leukemia virus. J. Natl. Cancer Inst. 29, 759 (1962).
Sjögren, H. O., Hellström, I., and Klein, G.: Transplantation of polyoma virus-induced tumor in mice. Cancer Res. 21, 329 (1961).
Sjögren, H. O., Hellström, I., and Klein, G.: Resistance of polyoma virus immunized mice to transplantation of established polyoma tumors. Exptl. Cell Res. 23, 204 (1961).
Sjögren, H. O.: Studies on specific transplantation resistance to polyoma-virus-induced tumors. IV. Stability of the polyoma cell antigen. J. Natl. Cancer Inst. 32, 661 (1964).
Sjögren, H. O.: Studies on specific transplantation resistance to polyoma-virus-induced tumors. I. Transplantation resistance induced by polyoma virus infection. J. Natl. Cancer Inst. 32, 361 (1964).
Slettenmark-Wahren, B., and Klein, E.: Cytotoxic and neutralization tests with serum and lymph node cells of isologous mice with induced resistance against gross lymphomas. Cancer Res. 22, 947 (1962).
Stück, B., Old, L. J., and Boyse, E. A.: Occurrence of soluble antigen in the plasma of mice with virus-induced leukemia. Proc. Natl. Acad. Sci. 52, 950 (1964).
Stück, B., Old, L. J., and Boyse, E. A.: Antigenic conversion of established leukaemias by an unrelated leukaemogenic virus. Nature 202, 1016 (1964).
Takemoto, K. K., Malmgren, R. A., and Habel, K.: Immunofluorescent demonstration of polyoma tumor antigen in lytic infection of mouse embryo cells. Virology, in press (1966).
Tevethia, S. S., Katz, M., and Rapp, F.: New surface antigen in cells transformed by simian papovavirus SV40. Proc. Soc. Exptl. Biol. Med. 119, 896 (1965).
Todaro, G. J., Habel, K., and Green, H.: Antigenic and cultural properties of cells doubly transformed by polyoma virus and SV40. Virology 27, 179 (1965).
Trentin, J. J., and Bryan, E.: Immunization of hamsters and histoisogenic mice against transplantation of tumors induced by human adenovirus type 12. Proc. Am. Assoc. Cancer Res. 5, 64 (1964).
Vanderputte, M., Denys, P., Jr., Leyten, R., and De Somer, P.: The oncogenic activity of the polyoma virus in thymectomized rats. Life Sci. 7, 475 (1963).
Vogt, M., and Dulbecco, R.: Studies on cells rendered neoplastic by polyoma virus the problem of the presence of virus-related materials. Virology 16, 41 (1962).
Vogt, P. K., and Luykx, N.: Observations on the surface of cells infected with Rous sarcoma virus. Virology 20, 75 (1963).
Vogt, P. K., Sarma, P. S., and Huebner, R. J.: Presence of avian tumor virus group-specific antigen in nonproducing Rous sarcoma cells of the chicken. Virology 27, 233 (1965).
Wahren, B.: Further studies of the immunological properties of Gross virus-induced lymphomas. Cancer Res. 24, 906 (1964).
Weiss, D. W., Faulkin, L. J., and DeOme, K. B.: Acquisition of heightened resistance and susceptibility to spontaneous mouse mammary carcinomas in the original host. Cancer Res. 24, 732 (1964).
Zilber, L. A.: Studies on tumor antigens. J. Natl. Cancer Inst. 18, 341 (1957).
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1966 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Habel, K. (1966). Specific Antigens Produced by Oncogenic Viruses. In: Kirsten, W.H. (eds) Malignant Transformation by Viruses. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 6. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-87402-4_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-87402-4_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-87404-8
Online ISBN: 978-3-642-87402-4
eBook Packages: Springer Book Archive